SCHEMBL5533359

SCHEMBL5533359

CCOc1ccc([N]C=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.56
ADRA2A P08913 2/20 0.52
ALDH1A1 P00352 5/20 0.50
KMT2A Q03164 2/20 0.50
CYP1A2 P05177 1/20 0.50
TSHR P16473 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
SCN1A P35498 1/20 0.45
SCN2A Q99250 1/20 0.45
SCN3A Q9NY46 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
PARP10 Q53GL7 1/20 0.44
RELA Q04206 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
LTA4H P09960 1/20 0.44
CASP1 P29466 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,4-Diethoxybenzene SCHEMBL11794798 0.78 NQO1 (0.93) NQO1ADRA2AALDH1A1TSHRTDP1
SCHEMBL5529092 0.77 ALDH1A1 (0.52) ALDH1A1KMT2ATSHRSMN1; SMN2CA12
SCHEMBL5532994 0.77 NQO1 (0.64) NQO1ADRA2AALDH1A1KMT2ACYP1A2
1,4-Diethoxybenzene SCHEMBL28074334 0.76 NQO1 (0.70) NQO1ALDH1A1KMT2ACYP1A2TSHR
SCHEMBL8762877 0.76 NQO1 (0.70) NQO1ADRA2AALDH1A1KMT2ACYP1A2
SCHEMBL8762872 0.76 NQO1 (0.70) NQO1ADRA2AALDH1A1KMT2ACYP1A2
SCHEMBL4401293 0.76 NQO1 (0.70) NQO1ADRA2AALDH1A1KMT2ACYP1A2
SCHEMBL230798 0.76 NQO1 (0.56) NQO1ADRA2AALDH1A1KMT2ACYP1A2
1,4-Diethoxybenzene SCHEMBL124015 0.75 NQO1 (1.00) NQO1ADRA2AALDH1A1TSHRTDP1
1,4-Diethoxybenzene SCHEMBL28186701 0.75 NQO1 (1.00) NQO1ADRA2AALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241770-B2 Hydronopol derivatives as agonists on human ORL1 receptors SOLVAY PHARMACEUTICALS GMBH (DE) 2007-07-10 US disclosed
US-20050131004-A1 Hydronopol derivatives as agonists on human ORL1 receptors SOLVAY PHARMACEUTICALS GMBH. 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131004-A1 Hydronopol derivatives as agonists on human ORL1 receptors OPRL1, ORMDL3, OGFRL1 NQO1 1865/4885ADRA2A 223/4885ALDH1A1 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.